New scan could spare men with Low-Risk prostate cancer from unnecessary biopsies

NCT ID NCT05948657

First seen Feb 28, 2026 · Last updated May 26, 2026 · Updated 13 times

Summary

This study is for men with low- or favorable intermediate-risk prostate cancer who are on active surveillance (watchful waiting). It tests whether a special PET/CT scan (PSMA-PET) can reliably rule out serious cancer, potentially reducing the need for yearly biopsies. About 200 participants will get the scan and a biopsy to compare results.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UCLA

    NOT_YET_RECRUITING

    Los Angeles, California, 90005, United States

    Contact Email: •••••@•••••

    Contact

  • UCSF

    NOT_YET_RECRUITING

    San Francisco, California, 94143, United States

    Contact

    Contact Email: •••••@•••••

  • UH Cleveland Medical Center

    RECRUITING

    Cleveland, Ohio, 44106, United States

    Contact

    Contact Email: •••••@•••••

  • Weill Cornell Medicine - New York Presbyterian Hospital

    RECRUITING

    New York, New York, 10065, United States

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.